Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice

Recently, accumulating evidence has suggested that gut microbiota may be involved in the occurrence and development of ankylosing spondylitis (AS). It has been suggested that rifaximin have the ability to modulate the gut bacterial communities, prevent inflammatory response, and modulate gut barrier...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lianjun, Liu, Bin, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Liu, Jinshi, Su, Zhihai, Wang, Min, Cui, Zhifei, Wang, Tingxuan, Zhang, Weicong, Li, Qingchu, Lu, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409347/
https://www.ncbi.nlm.nih.gov/pubmed/30886835
http://dx.doi.org/10.3389/fcimb.2019.00044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409347/
https://www.ncbi.nlm.nih.gov/pubmed/30886835
http://dx.doi.org/10.3389/fcimb.2019.00044

Ejemplares similares